Medtronic plc. (MDT) reported $37.54B of revenue for the twelve months ended Jul 31, 2026. That is up 9.8% from the year before. Revenue for fiscal 2026 was $36.36B.

Yes. Medtronic plc. earned $5.24B in net income for the twelve months ended Jul 31, 2026, a net margin of 14.0%.

How much cash and debt does MDT have?

Medtronic plc. reported $1.69B in cash and cash equivalents and $28.15B of debt on its most recent balance sheet in SEC filings.

How fast is MDT revenue growing?

Medtronic plc.'s revenue changed +8.4% in fiscal 2026, to $36.36B. Its compound annual growth rate was +3.8% over 5 years and +2.3% over 10 years.

What is MDT gross margin?

Medtronic plc.'s gross profit was $24.41B on $37.54B of revenue for the twelve months ended Jul 31, 2026, a gross margin of 65.0%.

What is MDT free cash flow?

Medtronic plc. generated $6.13B of free cash flow for the twelve months ended Jul 31, 2026, which is operating cash flow of $8.04B less capital expenditures.

What is MDT earnings per share?

Diluted earnings per share were $4.06 for the twelve months ended Jul 31, 2026, from SEC filings, restated for any stock split those filings show.

When did MDT last report financial results?

The latest statements here come from Medtronic plc.'s 10-Q filed on Sep 3, 2026, covering the period ended Jul 31, 2026.

Where does this MDT financial data come from?

Quantisnow builds these statements from the structured XBRL data Medtronic plc. files with the SEC. It is provided for information only and is not investment advice.

Financials · MDT

Medtronic plc. (MDT) financials

For the twelve months ended Jul 31, 2026, Medtronic plc. reported $37.54B of revenue and $5.24B of net income.

Revenue, TTM: $37.54B
Revenue growth, YoY: +9.8%
Net income, TTM: $5.24B
Net income growth, YoY: +12.2%
Net margin: 14.0%
Free cash flow, TTM: $6.13B
EPS, diluted, TTM: $4.06
EPS growth, YoY: +12.2%
Cash: $1.69B
Total debt: $28.15B
P/E: 24.86
P/S: 3.47
Market cap: $130.22B

Annual revenue$36.36B

FY2017FY2026

Annual net income$4.80B

FY2017FY2026

Annual free cash flow$5.43B

FY2017FY2026

MDT revenue and earnings growth

MDT revenueQ1 2027$9.76B

Quarter YoY: +13.7%
QoQ: -0.5%
FY YoY: +8.4%
5Y CAGR: +3.8%
10Y CAGR: +2.3%

MDT revenue was $9.76B in fiscal Q1 2027 (ended Jul 31, 2026), up 13.7% from a year earlier and down 0.5% from the prior quarter. For the full fiscal 2026 it was $36.36B, up 8.4% from fiscal 2025. Compound annual growth was +3.8% over 5 years and +2.3% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2026 is the highest of the 14 fiscal years on file.

MDT net incomeQ1 2027$1.47B

Quarter YoY: +41.3%
QoQ: +18.2%
FY YoY: +3.0%
5Y CAGR: +5.9%
10Y CAGR: +3.1%

MDT net income was $1.47B in fiscal Q1 2027 (ended Jul 31, 2026), up 41.3% from a year earlier and up 18.2% from the prior quarter. For the full fiscal 2026 it was $4.80B, up 3.0% from fiscal 2025. Compound annual growth was +5.9% over 5 years and +3.1% over 10 years. It rose in 6 of the last 10 fiscal years.

MDT EPSQ1 2027$1.14

Quarter YoY: +40.7%
QoQ: +18.8%
FY YoY: +3.3%
5Y CAGR: +7.0%
10Y CAGR: +4.2%

MDT diluted EPS was $1.14 in fiscal Q1 2027 (ended Jul 31, 2026), up 40.7% from a year earlier and up 18.8% from the prior quarter. For the full fiscal 2026 it was $3.73, up 3.3% from fiscal 2025. Compound annual growth was +7.0% over 5 years and +4.2% over 10 years.

MDT free cash flowQ1 2027$1.29B

Quarter YoY: +120.9%
QoQ: -38.1%
FY YoY: +4.6%
5Y CAGR: +2.1%
10Y CAGR: +2.7%

MDT free cash flow was $1.29B in fiscal Q1 2027 (ended Jul 31, 2026), up 120.9% from a year earlier and down 38.1% from the prior quarter. For the full fiscal 2026 it was $5.43B, up 4.6% from fiscal 2025. Compound annual growth was +2.1% over 5 years and +2.7% over 10 years. It rose in 6 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2026 Apr 24, 2026	FY2025 Apr 25, 2025	FY2024 Apr 26, 2024	FY2023 Apr 28, 2023	FY2022 Apr 29, 2022	FY2021 Apr 30, 2021	FY2020 Apr 24, 2020	FY2019 Apr 26, 2019	FY2018 Apr 27, 2018	FY2017 Apr 28, 2017
Revenue	$36.36B	$33.54B	$32.36B	$31.23B	$31.69B	$30.12B	$28.91B	$30.56B	$29.95B	$29.71B
Cost of revenue	$12.72B	$11.63B	$11.22B	$10.72B	$10.14B	$10.48B	$9.42B	$9.15B	$9.07B	$9.29B
Gross profit	$23.64B	$21.91B	$21.15B	$20.51B	$21.54B	$19.63B	$19.49B	$21.40B	$20.90B	$20.42B
Research and development	$2.87B	$2.73B	$2.73B	$2.70B	$2.75B	$2.49B	$2.33B	$2.33B	$2.26B	$2.19B
Selling, general and admin	$11.78B	$10.85B	$10.74B	$10.41B	$10.29B	$10.15B	$10.11B	$10.42B	$10.24B	$10.02B
Operating income	$6.47B	$5.96B	$5.14B	$5.49B	$5.75B	$4.48B	$4.79B	$6.27B	$6.64B	$5.38B
Interest expense	$715.00M	$729.00M	$719.00M	$636.00M	$553.00M	$925.00M	$1.09B	$1.44B	$1.15B	$1.09B
Pre-tax income	$6.14B	$5.63B	$4.84B	$5.36B	$5.52B	$3.90B	$4.05B	$5.20B	$5.67B	$4.60B
Income tax	$1.30B	$936.00M	$1.13B	$1.58B	$456.00M	$265.00M	-$751.00M	$547.00M	$2.58B	$578.00M
Net income	$4.80B	$4.66B	$3.68B	$3.76B	$5.04B	$3.61B	$4.79B	$4.63B	$3.10B	$4.03B
EPS, basic	$3.75	$3.63	$2.77	$2.83	$3.75	$2.68	$3.57	$3.44	$2.29	$2.92
EPS, diluted	$3.73	$3.61	$2.76	$2.82	$3.73	$2.66	$3.54	$3.41	$2.27	$2.89
Diluted shares	1.29B	1.29B	1.33B	1.33B	1.35B	1.35B	1.35B	1.36B	1.37B	1.39B

Balance sheet

Balance sheet
Line item	FY2026 Apr 24, 2026	FY2025 Apr 25, 2025	FY2024 Apr 26, 2024	FY2023 Apr 28, 2023	FY2022 Apr 29, 2022	FY2021 Apr 30, 2021	FY2020 Apr 24, 2020	FY2019 Apr 26, 2019	FY2018 Apr 27, 2018	FY2017 Apr 28, 2017
Cash and equivalents	$1.95B	$2.22B	$1.28B	$1.54B	$3.71B	$3.59B	$4.14B	$4.39B	$3.67B	$4.97B
Short-term investments	$7.27B	$6.75B	$6.72B	$6.42B	$6.86B	$7.22B	$6.81B	$5.46B	$7.56B	$8.74B
Receivables	$6.64B	$6.51B	$6.13B	$6.00B	$5.55B	$5.46B	$4.64B	$6.22B	$5.99B	$5.59B
Inventory	$5.95B	$5.48B	$5.22B	$5.29B	$4.62B	$4.31B	$4.23B	$3.75B	$3.58B	$3.34B
Current assets	$24.79B	$23.81B	$21.93B	$21.68B	$23.06B	$22.55B	$22.03B	$21.97B	$22.98B	$24.87B
Goodwill	$42.59B	$41.74B	$40.99B	$41.42B	$40.50B	$41.96B	$39.84B	$39.96B	$39.54B	$38.52B
Total assets	$93.03B	$91.68B	$89.98B	$90.95B	$90.98B	$93.08B	$90.69B	$89.69B	$91.39B	$99.86B
Current liabilities	$11.66B	$12.88B	$10.79B	$9.05B	$12.39B	$8.51B	$10.37B	$8.47B	$10.08B	$14.26B
Short-term debt	$1.79B	$2.87B	$1.09B	$20.00M	$3.74B	$11.00M	$2.78B	$838.00M	$2.06B	$7.52B
Long-term debt	$26.17B	$25.64B	$23.93B	$24.34B	$20.37B	$26.38B	$22.02B	$24.49B	$23.70B	$25.92B
Total debt	$27.96B	$28.52B	$25.02B	$24.36B	$24.11B	$26.39B	$24.80B	$25.32B	$25.76B	$33.44B
Total liabilities	$42.96B	$43.42B	$39.56B	$39.28B	$38.26B	$41.48B	$39.82B	$39.48B	$40.57B	$49.53B
Shareholders' equity	$49.46B	$48.26B	$50.42B	$51.66B	$52.72B	$51.60B	$50.87B	$50.21B	$50.82B	$50.33B

Cash flow

Cash flow
Line item	FY2026 Apr 24, 2026	FY2025 Apr 25, 2025	FY2024 Apr 26, 2024	FY2023 Apr 28, 2023	FY2022 Apr 29, 2022	FY2021 Apr 30, 2021	FY2020 Apr 24, 2020	FY2019 Apr 26, 2019	FY2018 Apr 27, 2018	FY2017 Apr 28, 2017
Operating cash flow	$7.33B	$7.04B	$6.79B	$6.04B	$7.35B	$6.24B	$7.23B	$7.01B	$4.68B	$6.88B
Capital expenditures	$1.90B	$1.86B	$1.59B	$1.46B	$1.37B	$1.35B	$1.21B	$1.13B	$1.07B	$1.25B
Free cash flow	$5.43B	$5.18B	$5.20B	$4.58B	$5.98B	$4.88B	$6.02B	$5.87B	$3.62B	$5.63B
Investing cash flow	-$2.93B	-$1.94B	-$2.37B	-$3.49B	-$1.66B	-$2.87B	-$3.20B	-$774.00M	$5.86B	-$1.57B
Financing cash flow	-$4.75B	-$4.36B	-$4.45B	-$4.96B	-$5.34B	-$4.14B	-$4.20B	-$5.43B	-$11.95B	-$3.28B
Dividends paid	$3.64B	$3.59B	$3.67B	$3.62B	$3.38B	$3.12B	$2.89B	$2.69B	$2.49B	$2.38B
Share repurchases	$1.03B	$3.23B	$2.14B	$645.00M	$2.54B	$652.00M	$1.33B	$2.88B	$2.17B	$3.54B
Stock-based compensation	$457.00M	$429.00M	$393.00M	$355.00M	$359.00M	$344.00M	$297.00M	$290.00M	$344.00M	$348.00M
Depreciation and amortization	$2.96B	$2.86B	$2.65B	$2.70B	$2.71B	$2.70B	$2.66B	$2.66B	$2.64B	$2.92B

Key ratios

Key ratios
Line item	FY2026 Apr 24, 2026	FY2025 Apr 25, 2025	FY2024 Apr 26, 2024	FY2023 Apr 28, 2023	FY2022 Apr 29, 2022	FY2021 Apr 30, 2021	FY2020 Apr 24, 2020	FY2019 Apr 26, 2019	FY2018 Apr 27, 2018	FY2017 Apr 28, 2017
Revenue growth, YoY	8.4%	3.6%	3.6%	-1.4%	5.2%	4.2%	-5.4%	2.0%	0.8%	3.0%
Net income growth, YoY	3.0%	26.8%	-2.2%	-25.4%	39.7%	-24.7%	3.4%	49.2%	-22.9%	13.8%
EPS growth, YoY	3.3%	30.8%	-2.1%	-24.4%	40.2%	-24.9%	3.8%	50.2%	-21.5%	16.5%
Gross margin	65.0%	65.3%	65.3%	65.7%	68.0%	65.2%	67.4%	70.0%	69.8%	68.7%
Operating margin	17.8%	17.8%	15.9%	17.6%	18.2%	14.9%	16.6%	20.5%	22.2%	18.1%
Net margin	13.2%	13.9%	11.4%	12.0%	15.9%	12.0%	16.6%	15.2%	10.4%	13.6%
Free cash flow margin	14.9%	15.5%	16.1%	14.7%	18.9%	16.2%	20.8%	19.2%	12.1%	18.9%
Return on equity	9.7%	9.7%	7.3%	7.3%	9.6%	7.0%	9.4%	9.2%	6.1%	8.0%
Return on assets	5.2%	5.1%	4.1%	4.1%	5.5%	3.9%	5.3%	5.2%	3.4%	4.0%
Current ratio	2.13	1.85	2.03	2.39	1.86	2.65	2.13	2.59	2.28	1.74
Debt to equity	0.57	0.59	0.50	0.47	0.46	0.51	0.49	0.50	0.51	0.66

Income statement

Income statement
Line item	Q1 2027 Jul 31, 2026	Q4 2026* Apr 24, 2026	Q3 2026 Jan 23, 2026	Q2 2026 Oct 24, 2025	Q1 2026 Jul 25, 2025	Q4 2025* Apr 25, 2025	Q3 2025 Jan 24, 2025	Q2 2025 Oct 25, 2024	Q1 2025 Jul 26, 2024	Q4 2024* Apr 26, 2024	Q3 2024 Jan 26, 2024	Q2 2024 Oct 27, 2023
Revenue	$9.76B	$9.81B	$9.02B	$8.96B	$8.58B	$8.93B	$8.29B	$8.40B	$7.92B	$8.59B	$8.09B	$7.98B
Cost of revenue	$3.42B	$3.40B	$3.26B	$3.06B	$3.00B	$3.15B	$2.78B	$2.95B	$2.76B	$3.04B	$2.78B	$2.76B
Gross profit	$6.34B	$6.41B	$5.76B	$5.90B	$5.58B	$5.78B	$5.51B	$5.46B	$5.15B	$5.54B	$5.31B	$5.22B
Research and development	$771.00M	$671.00M	$722.00M	$754.00M	$726.00M	$684.00M	$675.00M	$697.00M	$676.00M	$675.00M	$695.00M	$698.00M
Selling, general and admin	$3.20B	$3.06B	$2.96B	$2.96B	$2.81B	$2.72B	$2.72B	$2.76B	$2.65B	$2.77B	$2.67B	$2.69B
Operating income	$1.76B	$1.87B	$1.46B	$1.69B	$1.45B	$1.44B	$1.65B	$1.59B	$1.28B	$1.05B	$1.48B	$1.34B
Interest expense	$186.00M	$176.00M	$181.00M	$181.00M	$176.00M	$174.00M	$179.00M	$209.00M	$167.00M	$202.00M	$188.00M	$180.00M
Pre-tax income	$1.77B	$1.83B	$1.40B	$1.60B	$1.30B	$1.26B	$1.54B	$1.56B	$1.27B	$855.00M	$1.47B	$1.31B
Income tax	$289.00M	$575.00M	$254.00M	$215.00M	$255.00M	$199.00M	$237.00M	$281.00M	$220.00M	$197.00M	$135.00M	$402.00M
Net income	$1.47B	$1.24B	$1.14B	$1.38B	$1.04B	$1.06B	$1.29B	$1.28B	$1.05B	$654.00M	$1.32B	$911.00M
EPS, basic	$1.15	$0.98	$0.89	$1.07	$0.81	$0.82	$1.01	$0.99	$0.81	$0.51	$0.99	$0.68
EPS, diluted	$1.14	$0.96	$0.89	$1.07	$0.81	$0.81	$1.01	$0.99	$0.80	$0.50	$0.99	$0.68
Diluted shares	1.29B	-	1.29B	1.29B	1.29B	-	1.29B	1.29B	1.30B	-	1.33B	1.33B

Balance sheet

Balance sheet
Line item	Q1 2027 Jul 31, 2026	Q4 2026* Apr 24, 2026	Q3 2026 Jan 23, 2026	Q2 2026 Oct 24, 2025	Q1 2026 Jul 25, 2025	Q4 2025* Apr 25, 2025	Q3 2025 Jan 24, 2025	Q2 2025 Oct 25, 2024	Q1 2025 Jul 26, 2024	Q4 2024* Apr 26, 2024	Q3 2024 Jan 26, 2024	Q2 2024 Oct 27, 2023
Cash and equivalents	$1.69B	$1.95B	$1.15B	$1.28B	$1.27B	$2.22B	$1.24B	$1.39B	$1.31B	$1.28B	$1.62B	$1.31B
Short-term investments	$7.13B	$7.27B	$7.24B	$7.04B	$6.85B	$6.75B	$6.68B	$6.59B	$6.53B	$6.72B	$6.70B	$6.42B
Receivables	$6.36B	$6.64B	$6.36B	$6.39B	$6.26B	$6.51B	$6.12B	$6.26B	$6.01B	$6.13B	$5.97B	$5.93B
Inventory	$6.21B	$5.95B	$6.31B	$6.16B	$5.89B	$5.48B	$5.61B	$5.48B	$5.41B	$5.22B	$5.73B	$5.75B
Current assets	$24.39B	$24.79B	$24.07B	$24.00B	$23.22B	$23.81B	$22.51B	$22.44B	$21.95B	$21.93B	$22.51B	$22.08B
Goodwill	$43.19B	$42.59B	$41.89B	$41.81B	$42.01B	$41.74B	$40.82B	$41.16B	$41.08B	$40.99B	$41.16B	$40.82B
Total assets	$93.31B	$93.03B	$91.48B	$91.35B	$90.97B	$91.68B	$89.97B	$90.04B	$89.75B	$89.98B	$90.84B	$90.09B
Current liabilities	$11.80B	$11.66B	$9.49B	$9.94B	$11.53B	$12.88B	$11.84B	$12.20B	$10.29B	$10.79B	$9.79B	$9.66B
Short-term debt	$2.54B	$1.79B	$191.00M	$1.42B	$2.43B	$2.87B	$2.62B	$3.72B	$1.55B	$1.09B	$1.03B	$1.34B
Long-term debt	$25.62B	$26.17B	$27.88B	$27.68B	$26.18B	$25.64B	$23.98B	$24.61B	$26.31B	$23.93B	$24.15B	$23.74B
Total debt	$28.15B	$27.96B	$28.07B	$29.10B	$28.61B	$28.52B	$26.61B	$28.33B	$27.86B	$25.02B	$25.18B	$25.08B
Total liabilities	$42.46B	$42.96B	$42.29B	$42.49B	$42.84B	$43.42B	$40.36B	$41.33B	$41.59B	$39.56B	$38.84B	$38.44B
Shareholders' equity	$50.23B	$49.46B	$48.98B	$48.86B	$48.13B	$48.26B	$49.62B	$48.72B	$48.16B	$50.42B	$52.00B	$51.65B

Cash flow

Cash flow
Line item	Q1 2027 Jul 31, 2026	Q4 2026* Apr 24, 2026	Q3 2026 Jan 23, 2026	Q2 2026 Oct 24, 2025	Q1 2026 Jul 25, 2025	Q4 2025* Apr 25, 2025	Q3 2025 Jan 24, 2025	Q2 2025 Oct 25, 2024	Q1 2025 Jul 26, 2024	Q4 2024* Apr 26, 2024	Q3 2024 Jan 26, 2024	Q2 2024 Oct 27, 2023
Operating cash flow	$1.79B	$2.57B	$2.74B	$925.00M	$1.09B	$2.53B	$2.57B	$958.00M	$986.00M	$2.78B	$2.47B	$661.00M
Capital expenditures	$503.00M	$488.00M	$444.00M	$468.00M	$504.00M	$459.00M	$476.00M	$404.00M	$520.00M	$426.00M	$346.00M	$461.00M
Free cash flow	$1.29B	$2.08B	$2.30B	$457.00M	$584.00M	$2.07B	$2.10B	$554.00M	$466.00M	$2.35B	$2.13B	$200.00M
Investing cash flow	-$1.62B	-$917.00M	-$816.00M	-$482.00M	-$719.00M	-$490.00M	-$843.00M	-$345.00M	-$259.00M	-$696.00M	-$707.00M	-$424.00M
Financing cash flow	-$343.00M	-$888.00M	-$2.09B	-$395.00M	-$1.38B	-$1.34B	-$1.75B	-$534.00M	-$731.00M	-$2.36B	-$1.50B	-$90.00M
Dividends paid	$921.00M	$908.00M	$911.00M	$910.00M	$910.00M	$897.00M	$897.00M	$897.00M	$898.00M	$913.00M	$917.00M	$918.00M
Share repurchases	$267.00M	$435.00M	$105.00M	$372.00M	$123.00M	$274.00M	$181.00M	$288.00M	$2.49B	$1.63B	$132.00M	$226.00M
Stock-based compensation	$125.00M	$95.00M	$94.00M	$182.00M	$86.00M	$89.00M	$98.00M	$159.00M	$83.00M	$90.00M	$84.00M	$146.00M
Depreciation and amortization	$729.00M	$716.00M	$749.00M	$745.00M	$748.00M	$840.00M	$684.00M	$675.00M	$662.00M	$654.00M	$649.00M	$672.00M

Key ratios

Key ratios
Line item	Q1 2027 Jul 31, 2026	Q4 2026* Apr 24, 2026	Q3 2026 Jan 23, 2026	Q2 2026 Oct 24, 2025	Q1 2026 Jul 25, 2025	Q4 2025* Apr 25, 2025	Q3 2025 Jan 24, 2025	Q2 2025 Oct 25, 2024	Q1 2025 Jul 26, 2024	Q4 2024* Apr 26, 2024	Q3 2024 Jan 26, 2024	Q2 2024 Oct 27, 2023
Revenue growth, YoY	13.7%	9.9%	8.7%	6.6%	8.4%	3.9%	2.5%	5.2%	2.8%	0.5%	4.7%	5.3%
Net income growth, YoY	41.3%	17.8%	-11.7%	8.1%	-0.9%	61.5%	-2.1%	40.3%	31.6%	-44.5%	8.2%	109.4%
EPS growth, YoY	40.7%	18.5%	-11.9%	8.1%	1.2%	62.0%	2.0%	45.6%	35.6%	-43.2%	7.6%	112.5%
Gross margin	65.0%	65.4%	63.8%	65.8%	65.0%	64.7%	66.5%	64.9%	65.1%	64.6%	65.6%	65.4%
Operating margin	18.1%	19.1%	16.2%	18.8%	16.8%	16.1%	19.9%	19.0%	16.1%	12.3%	18.3%	16.8%
Net margin	15.1%	12.7%	12.7%	15.4%	12.1%	11.8%	15.6%	15.2%	13.3%	7.6%	16.3%	11.4%
Free cash flow margin	13.2%	21.3%	25.5%	5.1%	6.8%	23.2%	25.3%	6.6%	5.9%	27.4%	26.3%	2.5%
Current ratio	2.07	2.13	2.54	2.42	2.01	1.85	1.90	1.84	2.13	2.03	2.30	2.29
Debt to equity	0.56	0.57	0.57	0.60	0.59	0.59	0.54	0.58	0.58	0.50	0.48	0.49

Source: XBRL data Medtronic plc. files with the SEC, latest filing dated Sep 3, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

MDT peers

Company	Revenue	Growth	Net income	Net margin	Market cap
MDT	$37.54B	+9.8%	$5.24B	14.0%	$130.22B
LIVNLivaNova PLC	$1.51B	+11.7%	$196.06M	13.0%	$4.96B
ITGRInteger Holdings Corporation	$1.83B	-0.3%	$103.70M	5.7%	$4.30B
TMDXTransMedics Group Inc.	$727.65M	+28.5%	$144.45M	19.9%	$3.06B
AXGNAxogen Inc.	$266.93M	+24.3%	-$31.92M	-12.0%	$2.99B
CNMDCONMED Corporation	$1.37B	+1.6%	$73.43M	5.4%	$1.53B
CBLLCeriBell Inc.	$108.72M	+31.3%	-$73.88M	-68.0%	$1.03B
INMDInMode Ltd.	$370.50M	-6.2%	$93.83M	25.3%	$765.9M
CVCapsoVision Inc.	$13.89M	+11.0%	-$29.83M	-214.7%	$335.9M

MDT FAQ

9 questions

What is MDT revenue?
Medtronic plc. (MDT) reported $37.54B of revenue for the twelve months ended Jul 31, 2026. That is up 9.8% from the year before. Revenue for fiscal 2026 was $36.36B.
Is MDT profitable?
Yes. Medtronic plc. earned $5.24B in net income for the twelve months ended Jul 31, 2026, a net margin of 14.0%.
How much cash and debt does MDT have?
Medtronic plc. reported $1.69B in cash and cash equivalents and $28.15B of debt on its most recent balance sheet in SEC filings.
How fast is MDT revenue growing?
Medtronic plc.'s revenue changed +8.4% in fiscal 2026, to $36.36B. Its compound annual growth rate was +3.8% over 5 years and +2.3% over 10 years.
What is MDT gross margin?
Medtronic plc.'s gross profit was $24.41B on $37.54B of revenue for the twelve months ended Jul 31, 2026, a gross margin of 65.0%.
What is MDT free cash flow?
Medtronic plc. generated $6.13B of free cash flow for the twelve months ended Jul 31, 2026, which is operating cash flow of $8.04B less capital expenditures.
What is MDT earnings per share?
Diluted earnings per share were $4.06 for the twelve months ended Jul 31, 2026, from SEC filings, restated for any stock split those filings show.
When did MDT last report financial results?
The latest statements here come from Medtronic plc.'s 10-Q filed on Sep 3, 2026, covering the period ended Jul 31, 2026.
Where does this MDT financial data come from?
Quantisnow builds these statements from the structured XBRL data Medtronic plc. files with the SEC. It is provided for information only and is not investment advice.